DM-Tumor Markers

  1. What is Tumor marker:
    A substance produced by either a tumor or by the body in response to a tumor
  2. Name different substances that a tumor marker can be
    • Cell surface antigens
    • Cytoplasmic proteins
    • Enzymes
    • Hormones
    • Onco fetal antigens-
    • Receptors
    • Oncogenes
  3. How are Tumor Markers detected
    -•-Most common techniques are immunofluorescent or enzymatic assays- Most commonly used*

    -Monoclonal antibodies used to bind to marker of interest with a variety of visualization techniques
  4. Clinical Uses for tumor markers
    • 1. Screening and early detection- i.e. PSA, inexpensive test,
    • 2. Diagnostic confirmation-
    • 3. Prognosis and prediction of therapeutic response
    • 4. Monitoring disease and recurrence-
  5. Factors that will affect tumor markers
    • • Aging (PSA)
    • • Metabolism and elimination of marker
    • • Kidney or liver disease
    • • Messing with metabolism and elimination of the markers
    • • Hormonal imbalances (thyroid affecting metabolism or production)
    • • Smoking
    • • Alcoholism
    • • Obesity
  6. Partial remission is signify by?
    reduction of markers by 50%
  7. How are the markers seen in recurance of disease?
    Incease of 25% or more of marker
  8. If no recent treatment, and there a rise on logarithmic scale on 3 samples, what does this signify?
    is confirmatory of disease
  9. MARKERS TO KNOW
    • 1. HCG          testes, breast, ovary, GI, lung
    • 2. CA 125      Ovarian
    • 3. HER-2       Breast prognosis
    • 4. CA 19-9    Pancreatic
    • 5. PSA          Prostate
    • 6. CEA          Colon+
    • 7. AFP           liver
  10. Carbohydrate antigen 125 (CA125)
    Carbohydrate chain coded for on the MUC1 gene; production increases to detectable levels with certain cancers
  11. Carbohydrate antigen 125 (CA125) is associated with what cancer?
    • BLOPE
    • b= breast cancer
    • L = lung cancer
    • O= OVARIAN CANCER
    • p= pancreatic cancer
    • e=endomitrial cancer
  12. For Non-cancerous elevation, CA 125 is seen in?
    Endometriosis, PID, pregnancy, acute pancreatitis
  13. how can Carbohydrate antigen 125 (CA125) be used?
    Used to monitor response to treatment and watch for *RECURENT of disease*, and FOLLOW high risk females w/  + family hx
  14. Carcinoembryonic Antigen (CEA)
    Endogenous glycoprotein that helps with aggregation of colorectal carcinoma cells

    produced neonatal development, hold cells together in GI
  15. Carcinoembryonic Antigen (CEA) is associated with which cancers?
    • COLORECTAL CANCER, metastatic breast cancer, lung CA, pancreatic CA, hepatocellular CA-
    • (LaMb CHoP)

    high levels are GI associated, and seen in smokers
  16. Non cancerous elevation of Carcinoembryonic Antigen (CEA) is seen in
    Noncancerous elevations: Cholangitis, cholelithiasis, chronic hepatitis, COPD, IBD

    (ICCCC or I 4C)
  17. how is Carcinoembryonic Antigen (CEA) marker used?
    Usage: Establish prognosis, monitoring therapeutic effectiveness, recognizing recurrent disease in colon CA
  18. Alpha fetoprotein (AFP)
    Germ cell tumors, HEPATOCELLULAR CARCINOMA, non-seminomatous testicular cancers

    -Used to detect tumors of the *liver and testes/ovaries* (germ cell)-slight elevation seen in hepatitis or cirrhosis

    -The higher the level the bigger the tumor
  19. Alpha fetoprotein (AFP) can be used for what else?
    Antenatal diagnosis of trisomy 21( down syndrome) and neurologic congenital defects
  20. Non cancerous elevation of Alpha fetoprotein (AFP) is seen in?
    Noncancerous elevations: viral hepatitis, liver injury, pregnancy, inflammatory bowel disease

    (VLIP)
  21. Beta Human Chorionic Gonadotropin (beta HCG)
    Glycoprotein hormone usually produced by the placenta during pregnancy
  22. Beta Human Chorionic Gonadotropin (beta HCG) is associated with what type of cancer
    Choriocarcinoma, Germ cell tumors, testicular cancers

    secondary marker for breast cancer, stomach cancer, ovarian cancer, colon cancer
  23. True or false? Beta Human Chorionic Gonadotropin (beta HCG) is excellent marker for screening
    Only used to monitor disease following treatment, *not used in screening*

    -elevated in pregnancy, not a preferred marker in colon cancer.
  24. Prostate-Specific Antigen (PSA)
    o Glycoprotein normally produced by prostate

    • o Associated malignancies: Prostate Cancer
    • o Usage: Some debate about utility in screening
  25. Noncancerous elevation of Beta Human Chorionic Gonadotropin (beta HCG) is seen in
    Testicular failure, marijuana, pregnancy
  26. When is Prostate-Specific Antigen (PSA) false positive?
    Rise in PSA can also be  due to Prostatitis, BPH, aging
  27. HER-2/neu
    Oncogene on 17qo Associated diseases: Breast Cancer, Ovarian CA, Endometrial CA, other cancers

    Usage: *Assessing for susceptibility to hormonal therapies*

    • High levels of gene transcription indicates lower numbers of estrogen and progesterone receptors and therefore lower response to hormonal treatments

    Specimen: Biopsy

    breast cancer gene, will this help or hinder during tx, if gene is over expressed
  28. How is HER-2/neu normally tested
    Usually tested in conjunction with ER and PR (estrogen and progesterone receptor)

    • Reported as HER2( )/ER ( )/PR ( ) where the parentheses indicate positive or negative
  29. ER+/PR+ mean what
    are more likely to respond to hormonal treatments and generally have a slower-growing tumor
  30. HER-2 positive indicates what?
    -indicates higher risk of relapse and decreased survival time-however, there are drugs that are specific for this protein, so prognosis is good w/ treatment
  31. "Triple negative" means what?
    = HER-2 (-), ER-/PR-is an indicator of a poorer prognosis in breast cancer
  32. Explain why "Triple negative" is not good
    when all three markers are negative, there is reduced respond to drug therapy, thus poor prognosis
  33. Noncancerous elevations of CA 19-9 is seen in
    Noncancerous elevations: Acute pancreatitis, cholangitis, cirrhosis
  34. CA 19-9
    Certain product of MUC1 genes

    Seen in PANCREATIC MALIGNANCIES, Hepatobiliary carcinoma, Colorectal cancer
  35. CA 19-9 is used for screening?
    NO, Used for monitoring disease progression and recurrence rather than detection; used in conjunction with CEA

    not intially elevated in all pancreatic cancer

    once elevated, cancer is at advanced stage
Author
Bic
ID
327567
Card Set
DM-Tumor Markers
Description
tumor markers for oncology
Updated